Results 1 to 10 of about 6,988,155 (300)

Virus-like particles in vaccine development

Expert Review of Vaccines, 2010
Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccine candidates. A handful of prophylactic VLP-based vaccines is currently commercialized worldwide: GlaxoSmithKline's Engerix (hepatitis B virus) and ...
Manuel J T Carrondo, Leda R Castilho, António Roldão   +2 more
exaly   +3 more sources

Virus-like particles: flexible platforms for vaccine development

Expert Review of Vaccines, 2007
Bryce Chackerian
exaly  

RNA-Directed Packaging of Enzymes within Virus-like Particles†

Angewandte Chemie - International Edition, 2010
MG Finn, Jason D Fiedler
exaly  

VIRUS-LIKE PARTICLES IN SERUM OF PATIENTS WITH AUSTRALIA-ANTIGEN-ASSOCIATED HEPATITIS

Lancet, The, 1970
C H Cameron, D S Dane, Moya Briggs
exaly  

Virus-like particles: Passport to immune recognition

Methods, 2006
David Anderson
exaly  

Stabilization of Virus-like Particles with Poly(2-oxazoline)s†

Angewandte Chemie - International Edition, 2011
Robert Luxenhofer, MG Finn, Rainer Jordan   +2 more
exaly  

An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles

Vaccine, 2008
Hugh S Mason, Zhong Huang, Qiang Chen
exaly  

Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer

Expert Opinion on Biological Therapy, 2007
Tina Dalianis, Torbjörn Ramqvist, Kalle Andréasson   +2 more
exaly  

Production of virus-like particles for vaccines

New Biotechnology, 2017
Laura Cervera, Javier Fuenmayor, F Godia
exaly  

virus-like particles: assembly and stability

Biochimie, 2012
Jonathan Dordick, Ismael Bustos-Jaimes
exaly